Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trautwein

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Cell Death & Disease|March 6, 2015
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN modelM Hatting, M Spannbauer, J Peng, et al.
Hepatology (Baltimore, Md.)|January 1, 1997
Long-term outcome of hepatitis C virus infection after liver transplantationK H Böker, G Dalley, M J Bahr, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1996
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot studyM Krüger, H L Tillmann, C Trautwein, et al.
International Journal of Immunogenetics|November 16, 2007
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6J J W Tischendorf, E Yagmur, D Scholten, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signalingJ E Ros, J D Schuetz, M Geuken, et al.
Endoscopy|November 10, 2009
Value of magnifying endoscopy in classifying colorectal polyps based on vascular patternJ J W Tischendorf, R Schirin-Sokhan, K Streetz, et al.
The Journal of Infectious Diseases|June 2, 1998
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?S Heringlake, J Ockenga, H L Tillmann, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 19, 2013
[Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment. A retrospective analysis from 1999 to 2010]A Koch, L Buendgens, H Dückers, et al.
Cancer Research|May 15, 1997
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinomaX Li, Z Nong, C Ekström, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Cell Death & Disease|March 6, 2015
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN modelM Hatting, M Spannbauer, J Peng, et al.
Hepatology (Baltimore, Md.)|January 1, 1997
Long-term outcome of hepatitis C virus infection after liver transplantationK H Böker, G Dalley, M J Bahr, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1996
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot studyM Krüger, H L Tillmann, C Trautwein, et al.
International Journal of Immunogenetics|November 16, 2007
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6J J W Tischendorf, E Yagmur, D Scholten, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signalingJ E Ros, J D Schuetz, M Geuken, et al.
Endoscopy|November 10, 2009
Value of magnifying endoscopy in classifying colorectal polyps based on vascular patternJ J W Tischendorf, R Schirin-Sokhan, K Streetz, et al.
The Journal of Infectious Diseases|June 2, 1998
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?S Heringlake, J Ockenga, H L Tillmann, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 19, 2013
[Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment. A retrospective analysis from 1999 to 2010]A Koch, L Buendgens, H Dückers, et al.
Cancer Research|May 15, 1997
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinomaX Li, Z Nong, C Ekström, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Pageof 18